Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.
暂无分享，去创建一个
M. Whitfield | L. Rice | Jessica Ziemek | R. Simms | J. Gordon | R. Lafyatis | J. Weinberg | R. Christmann | R. Spiera | M. York | Sashidhar S. Nakerakanti | Cristina M Padilla | G. Farina | Sarah Mclaughlin | Salma Goummih | Allison L. Mathes